ArticleNature communications2018

miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.

Anne-Marie Givel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.